Non- Insulin based diabetes therapies

Type 2 Diabetes, also known as adult-onset diabetes, is a type of diabetes characterised by high blood sugar, insulin resistance, and a relative lack of insulin. Symptoms may also include increased hunger, fatigue, and unhealed sores. Long-term complications of diabetes include heart disease, strokes, diabetic retinopathy (which can lead to blindness), kidney failure, and poor blood flow in the limbs, which can lead to amputations. The primary metabolic effect of this is to inhibit glucose reabsorption in the kidney, lowering blood sugar. They work by inhibiting the sodium-glucose transport protein 2 (SGTP2) (SGLT2). Type II diabetes mellitus is treated with SGLT2 inhibitors (T2DM).

  • Nutrition and diet
  • Oral therapies: metformin, sensitizers and other non-secretagogues
  • SGLT inhibitors
  • Incretin-based therapies
  • Novel agents

Related Conference of Non- Insulin based diabetes therapies

November 13-14, 2024

33rd International Diabetes and Healthcare Conference

Paris, France
November 18-19, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
November 18-19, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland

Non- Insulin based diabetes therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in